definiens: shall meanany agreement executed by [COMPANY] or any of its Affiliates under which any ofDebiopharm 's rights under the license granted to [COMPANY] pursuant to Section 2.1are sublicensed ; provided, however, that the term Commercial Sublicense Agreementshall exclude any agreement between [COMPANY] or its Affiliate and a Third Partyservice provider under which a sublicense is granted to such Third Party for the solepurpose of enabling such Third Party to perform contract services on behalf ofDebiopharm or its Affiliate ( e. g., contract research or development organizations, clinicalsites performing clinical trials, universities and scientific institutes, and contractmanufacturing organizations ) . In addition, [COMPANY] shall notify [COMPANY] in writing of thetermination of any Commercial Sublicense Agreement within thirty ( 30 ) days after suchtermination . If [COMPANY] determines that there is a reasonable likelihood of itsexecution of a Commercial Sublicense Agreement or an amendment to, or terminationof, an existing Commercial Sublicense Agreement, [COMPANY] shall use reasonableefforts to provide notice thereof to [COMPANY], which notice shall be provided solely for Curis'information and planning purposes . No sublicense hereunder shall limit or affect theobligations of [COMPANY] under this Agreement, and [COMPANY] shall remain fullyresponsible for each Affiliate 's or Sublicensee 's compliance with the applicable termsand conditions of this Agreement